Literature DB >> 33717098

Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.

Chao Hong1, Rong Jin1, Xiaoqiu Dai1, Xiaoming Gao1.   

Abstract

Chronic graft-versus-host disease (cGVHD) is one of the most common reasons of late non-relapse morbidity and mortality of patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT). While acute GVHD is considered driven by a pathogenic T cell dominant mechanism, the pathogenesis of cGVHD is much complicated and involves participation of a variety of immune cells other than pathogenic T cells. Existing studies have revealed that antigen presenting cells (APCs) play crucial roles in the pathophysiology of cGVHD. APCs could not only present auto- and alloantigens to prime and activate pathogenic T cells, but also directly mediate the pathogenesis of cGVHD via multiple mechanisms including infiltration into tissues/organs, production of inflammatory cytokines as well as auto- and alloantibodies. The studies of this field have led to several therapies targeting different APCs with promising results. This review will focus on the important roles of APCs and their contributions in the pathophysiology of cGVHD after allo-HSCT.
Copyright © 2021 Hong, Jin, Dai and Gao.

Entities:  

Keywords:  allogeneic hematopoietic stem cell transplantation; antigen presenting cells; chronic graft versus host disease; immune regulation; immune tolerance

Mesh:

Year:  2021        PMID: 33717098      PMCID: PMC7943746          DOI: 10.3389/fimmu.2021.614183

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  145 in total

Review 1.  Cytokine mediators of chronic graft-versus-host disease.

Authors:  Kelli Pa MacDonald; Bruce R Blazar; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

2.  Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.

Authors:  Christopher G Kanakry; Hua-Ling Tsai; Javier Bolaños-Meade; B Douglas Smith; Ivana Gojo; Jennifer A Kanakry; Yvette L Kasamon; Douglas E Gladstone; William Matsui; Ivan Borrello; Carol Ann Huff; Lode J Swinnen; Jonathan D Powell; Keith W Pratz; Amy E DeZern; Margaret M Showel; Michael A McDevitt; Robert A Brodsky; Mark J Levis; Richard F Ambinder; Ephraim J Fuchs; Gary L Rosner; Richard J Jones; Leo Luznik
Journal:  Blood       Date:  2014-10-14       Impact factor: 22.113

Review 3.  Pathogenesis and management of graft-versus-host disease.

Authors:  Sung W Choi; John E Levine; James L M Ferrara
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

4.  Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.

Authors:  V Ratanatharathorn; E Carson; C Reynolds; L J Ayash; J Levine; G Yanik; S M Silver; J L Ferrara; J P Uberti
Journal:  Ann Intern Med       Date:  2000-08-15       Impact factor: 25.391

5.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Authors:  Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette Kasamon; Steven N Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

6.  Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.

Authors:  Lucie Leveque-El Mouttie; Motoko Koyama; Laetitia Le Texier; Kate A Markey; Melody Cheong; Rachel D Kuns; Katie E Lineburg; Bianca E Teal; Kylie A Alexander; Andrew D Clouston; Bruce R Blazar; Geoffrey R Hill; Kelli P A MacDonald
Journal:  Blood       Date:  2016-06-23       Impact factor: 22.113

7.  Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.

Authors:  Ruishu Deng; Christian Hurtz; Qingxiao Song; Chanyu Yue; Gang Xiao; Hua Yu; Xiwei Wu; Markus Muschen; Stephen Forman; Paul J Martin; Defu Zeng
Journal:  Nat Commun       Date:  2017-10-17       Impact factor: 14.919

8.  Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.

Authors:  Rong Hu; Yalan Liu; Min Su; Yinhong Song; Debra Rood; Laijun Lai
Journal:  Stem Cells Transl Med       Date:  2016-08-02       Impact factor: 6.940

Review 9.  Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance.

Authors:  Hongshuang Yu; Yuanyuan Tian; Ying Wang; Shin Mineishi; Yi Zhang
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 10.  Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD).

Authors:  Matthew Mankarious; Nick C Matthews; John A Snowden; Arun Alfred
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

View more
  2 in total

1.  Gene expression profile of chronic oral graft-versus-host disease.

Authors:  Giselle Rocha Pinto; Viviane Almeida Sarmento; Paulo Cirino de Carvalho-Filho; Vitor Antonio Fortuna; Ryan Dos Santos Costa; Rogério Reis Conceição; Soraya Castro Trindade
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

2.  Neutrophils as regulators of macrophage-induced inflammation in a setting of allogeneic bone marrow transplantation.

Authors:  Chao Hong; Hongyun Lu; Xiaohong Huang; Ming Chen; Rong Jin; Xiaoqiu Dai; Fangyuan Gong; Hongliang Dong; Hongmin Wang; Xiao-Ming Gao
Journal:  Stem Cell Reports       Date:  2022-06-30       Impact factor: 7.294

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.